tailor-measuring-shirt
19 February 2014Robert Andrews

Personalised medicine in Europe: is the patent system keeping up?

In the not-so-distant past, obtaining patent protection for a new therapeutic drug (or new use of a known drug) was simpler than it is today. The therapeutic landscape was comparatively unexplored, and our knowledge of disease pathology was uninformed by the battery of molecular techniques available today. This lack of detailed information meant the factors to consider when assessing a new therapeutic application were relatively few and, consequently, the required analysis was relatively straightforward.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
20 November 2026   A US patent board finds two Halozyme patents unpatentable, while a German appeals court overturns an injunction blocking the subcutaneous version of Keytruda, marking two setbacks for Halozyme in its ongoing dispute with the pharma giant.
Careers
19 November 2026   The seven-partner team are some of the “most accomplished” IP trial lawyers in the country, bringing extensive experience in patent, trade secret and commercial disputes for major technology and life sciences companies.
Careers
19 November 2026   The leadership change marks the end of Bradley’s 15-year tenure at BMS, during which she also served as INTA president for one year.